Analytical Data
-
基因名
Major capsid 蛋白 VP1
- Application
-
别名
Major structural protein VP1
-
种属
Rattus norvegicus polyomavirus 2
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A0A2Z2DSF0
-
表达区间
1-344aa
-
分子量
44.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of the Major Capsid Protein VP1, a key structural component of various viruses, has garnered significant attention in virology and biotechnology. VP1 is pivotal in forming the viral capsid, providing protection to the viral genome while also playing a crucial role in the virus's ability to attach to and infect host cells. The ability to produce recombinant VP1 protein has opened new avenues for research and therapeutic development. Techniques such as recombinant DNA technology allow for the expression of VP1 in host systems, facilitating the study of its structure, function, and immunogenic properties. Understanding VP1 can lead to advancements in vaccine design, as it is often a target for the immune response. Moreover, because of its stable and immunogenic characteristics, VP1 has potential applications in developing diagnostic tools and as a platform for delivering other antigens. The ongoing research into VP1 not only enhances our comprehension of viral pathogenesis but also contributes to innovative strategies in emerging infectious disease control and prevention.
